Apr 30 |
et al., Molecules, doi:10.3390/molecules30092004 | Silver Nanoparticles (AgNPs) as Potential Antiviral Agents: Synthesis, Biophysical Properties, Safety, Challenges and Future Directions─Update Review |
| Review of silver nanoparticles (AgNPs) as antiviral agents, focusing on their synthesis methods, biophysical properties, safety concerns, and antiviral mechanisms. Authors highlight that AgNPs exhibit promising broad-spectrum antiviral ac.. | ||
Mar 28 |
et al., Global Challenges, doi:10.1002/gch2.202400380 | Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review |
| Review of silver nanoparticle-mediated antiviral efficacy against enveloped viruses, with particular focus on SARS-CoV-2. Authors examine how AgNPs exhibit broad-spectrum antiviral activity through multiple mechanisms including direct int.. | ||
Mar 31 2023 |
et al., Heliyon, doi:10.1016/j.heliyon.2023.e14419 | Reduction in the COVID-19 pneumonia case fatality rate by silver nanoparticles: A randomized case study |
| 56% lower mortality (p=0.01). RCT 40 late stage hospitalized COVID-19 patients on oxygen showing significantly higher survival rates with intravenous silver nanoparticles (AgNPs). Authors suggest that antiviral, anti-inflammatory, antiplatelet, and antimicrobial prope.. | ||
Aug 19 2021 |
et al., PLOS ONE, doi:10.1371/journal.pone.0256401 | Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo |
| 94% fewer cases (p<0.0001) and 49% improvement (p=0.003). RCT 231 healthcare workers showing significantly lower COVID-19 infection rates with silver nanoparticle (AgNPs) oral and nasal rinses. Authors also report in vitro experiments showing dose-dependent inhibition in cell cultures. | ||
Please send us corrections, updates, or comments.
c19early involves the extraction of 200,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. IMA and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.